Priority Date: 21.10.11 (US 201161549862P)

HYBRID DIAZENIUMDIOLATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHOD OF TREATING CANCER

  • Application ID: EP12841601
  • Status: PATENT GRANTED

Attorney

Employment test 11 - 50 employees
Company dna pfennig meinig and partner
operating since 1878
Headquarter in Berlin and 2 offices
active in Legal Services and IP Consulting

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 190 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 21.10.2011 - Priority Date (US 201161549862P)
  • 25.04.2013 - Publication A2 (WO2013059433)
  • 27.08.2014 - Publication A2 (EP2768824)
  • 07.12.2016 - Publication B1 (EP2768824)